These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10801472)

  • 1. In vitro selection of a novel nuclease-resistant RNA phosphodiesterase.
    Beaudry A; DeFoe J; Zinnen S; Burgin A; Beigelman L
    Chem Biol; 2000 May; 7(5):323-34. PubMed ID: 10801472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection, design, and characterization of a new potentially therapeutic ribozyme.
    Zinnen SP; Domenico K; Wilson M; Dickinson BA; Beaudry A; Mokler V; Daniher AT; Burgin A; Beigelman L
    RNA; 2002 Feb; 8(2):214-28. PubMed ID: 11911367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High cleavage activity and stability of hammerhead ribozymes with a uniform 2'-amino pyrimidine modification.
    Leirdal M; Sioud M
    Biochem Biophys Res Commun; 1998 Sep; 250(1):171-4. PubMed ID: 9735351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial tertiary motifs stabilize trans-cleaving hammerhead ribozymes under conditions of submillimolar divalent ions and high temperatures.
    Saksmerprome V; Roychowdhury-Saha M; Jayasena S; Khvorova A; Burke DH
    RNA; 2004 Dec; 10(12):1916-24. PubMed ID: 15547137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.
    Vaish NK; Heaton PA; Fedorova O; Eckstein F
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2158-62. PubMed ID: 9482855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance.
    Beigelman L; McSwiggen JA; Draper KG; Gonzalez C; Jensen K; Karpeisky AM; Modak AS; Matulic-Adamic J; DiRenzo AB; Haeberli P
    J Biol Chem; 1995 Oct; 270(43):25702-8. PubMed ID: 7592749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M; Homann M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages.
    Shimayama T; Nishikawa F; Nishikawa S; Taira K
    Nucleic Acids Res; 1993 Jun; 21(11):2605-11. PubMed ID: 8332458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal Hammerhead Ribozymes with Uncompromised Catalytic Activity.
    O'Rourke SM; Estell W; Scott WG
    J Mol Biol; 2015 Jul; 427(14):2340-7. PubMed ID: 25981451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evolution of the hammerhead ribozyme to a purine-specific ribozyme using mutagenic PCR with two nucleotide analogues.
    Kore AR; Vaish NK; Morris JA; Eckstein F
    J Mol Biol; 2000 Sep; 301(5):1113-21. PubMed ID: 10966809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified binary hammerhead ribozymes with high catalytic activity.
    Vorobjeva M; Gusseva E; Repkova M; Kovalev N; Zenkova M; Venyaminova A; Vlassov V
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):1105-9. PubMed ID: 16248101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of active ribozymes from an RNA pool of random sequences using an anchored substrate RNA.
    Ishizaka M; Ohshima Y; Tani T
    Biochem Biophys Res Commun; 1995 Sep; 214(2):403-9. PubMed ID: 7545903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate specificity and reaction kinetics of an X-motif ribozyme.
    Lazarev D; Puskarz I; Breaker RR
    RNA; 2003 Jun; 9(6):688-97. PubMed ID: 12756327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J; Breaker RR
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evolution suggests multiple origins for the hammerhead ribozyme.
    Salehi-Ashtiani K; Szostak JW
    Nature; 2001 Nov; 414(6859):82-4. PubMed ID: 11689947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative single-turnover kinetic analyses of trans-cleaving hammerhead ribozymes with naturally derived non-conserved sequence motifs.
    Weinberg MS; Rossi JJ
    FEBS Lett; 2005 Mar; 579(7):1619-24. PubMed ID: 15757651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic activity and stability of hammerhead ribozymes containing 2'-acetamido-2'-deoxyribonucleosides.
    Hendrix C; Mahieu M; Anné J; Van Calenbergh S; Van Aerschot A; Content J; Herdewijn P
    Biochem Biophys Res Commun; 1995 May; 210(1):67-73. PubMed ID: 7741750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection of hammerhead ribozymes containing a bulged nucleotide in stem II.
    Thomson JB; Sigurdsson ST; Zeuch A; Eckstein F
    Nucleic Acids Res; 1996 Nov; 24(22):4401-6. PubMed ID: 8948630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AUA-cleaving hammerhead ribozymes: attempted selection for improved cleavage.
    Nakamaye KL; Eckstein F
    Biochemistry; 1994 Feb; 33(5):1271-7. PubMed ID: 8110761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb.
    Jarvis TC; Wincott FE; Alby LJ; McSwiggen JA; Beigelman L; Gustofson J; DiRenzo A; Levy K; Arthur M; Matulic-Adamic J; Karpeisky A; Gonzalez C; Woolf TM; Usman N; Stinchcomb DT
    J Biol Chem; 1996 Nov; 271(46):29107-12. PubMed ID: 8910566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.